Derek Hicks, EVP, Chief Business Officer at Intellia Therapeutics, Inc. (NTLA), sold 3,624 shares at $37.21 ($135K) on 2023-01-04, disclosed to the SEC on 2023-01-06.
Open-market sale of $135k NTLA by EVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.21 | 1,812 | $67K | 50.0% |
| 2 | $37.21 | 1,812 | $67K | 50.0% |
| Total | $37.21 avg | 3,624 | $135K | 100% |
| Filing → |